Monitor for release of the full filing to assess the nature of the disclosed event and any potential impact on the company's operations or financial outlook.
Price Chart
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The 8-K filing includes Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), suggesting Cadrenal Therapeutics may have disclosed public information, announced an event such as litigation or regulatory action, and filed related exhibits. Without access to the actual filing content, no specific financial or operational impact can be determined.
Key Facts
- Filing is an 8-K for Cadrenal Therapeutics, Inc. (CVKD)
- Items reported: 7.01 (Regulation FD Disclosure), 8.01 (Other Events), 9.01 (Financial Statements and Exhibits)
- No document content available for analysis
- Market cap of CVKD is $18M as per snapshot
Financial Impact
Not specified
Risk Factors
- Material adverse event possible under Item 8.01 (e.g., litigation, regulatory action)
- Potential for dilutive financing or share issuance not confirmed
- Low market cap increases volatility risk if material news is disclosed
Market Snapshot
Investment Themes
Documents Analyzed
Report based on filing metadata.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 19d ago | 8-K | $0.9723 | awaiting T+60 | — | $0.9298 (−4.37%) |
Aug 31, 2026 8w ago | 8-K | $1.75 | awaiting T+60 | — | $0.9298 (−46.87%) |
Jul 21, 2026 13w ago | 8-K | $2.17 $0.9970 | ▼ −54.06% | ▼ −58.03% | $0.9298 (−57.15%) |
Jul 21, 2026 13w ago | EFFECT | $2.17 $0.9970 | ▼ −54.06% | ▼ −58.03% | $0.9298 (−57.15%) |
Jul 1, 2026 16w ago | Press Release | $3.60 $1.12 | ▲ +68.89% | ▲ +71.94% | $0.9298 (+74.17%) |
Jun 29, 2026 16w ago | 8-K | $3.34 $1.32 | ▼ −60.48% | ▼ −64.04% | $0.9298 (−72.16%) |
Jun 18, 2026 18w ago | 8-K | $3.50 $1.06 | ▼ −69.71% | ▼ −71.61% | $0.9298 (−73.43%) |
Jun 15, 2026 18w ago | 144 | $3.04 $1.18 | ▲ +61.18% | ▲ +62.18% | $0.9298 (+69.41%) |
May 7, 2026 24w ago | Press Release | $6.02 $1.96 | ▼ −67.44% | ▼ −71.27% | $0.9298 (−84.55%) |
Apr 30, 2026 25w ago | 8-K | $6.67 $2.06 | ▼ −69.12% | ▼ −72.22% | $0.9298 (−86.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers